Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.

作者: A.D. Steele , B. De Vos , J. Tumbo , J. Reynders , F. Scholtz

DOI: 10.1016/J.VACCINE.2008.08.034

关键词:

摘要: A double-blind, placebo-controlled phase II trial (e-Track 444563-014/NCT00346892) was conducted in South Africa to evaluate the co-administration of RIX4414 (live-attenuated human G1P[8] rotavirus vaccine) and oral poliovirus vaccine (OPV) administered simultaneously. Healthy infants (n=450) were randomized into three groups (RIX4414+OPV, RIX4414+IPV or Placebo+OPV) receive two doses RIX4414/placebo with OPV IPV using vaccination schedules (6-10 weeks 10-14 weeks). Serum anti-rotavirus IgA antibodies (ELISA) neutralizing (micro-neutralization assay) serotypes 1, 2 3 measured. Co-administration did not result a decrease high sero-protection rates against detected after third dose (98-100%). The antibody sero-conversion higher for schedule (55-61%) compared 6-10 (36-43%). Solicited symptoms reported at similar between placebo no serious adverse events related reported. This study provided evidence that can be co-administered routine EPI immunizations including well tolerated immunogenic African infants.

参考文章(28)
L. Roberts, POLIO ENDGAME: Polio: The Final Assault? Science. ,vol. 303, pp. 1960- 1968 ,(2004) , 10.1126/SCIENCE.303.5666.1960
Margaret B Rennels, Roger I Glass, Penelope H Dennehy, David I Bernstein, Michael E Pichichero, Edward T Zito, Michael E Mack, Bruce L Davidson, Albert Z Kapikian, United States Rotavirus Vaccine Efficacy Group, Safety and Efficacy of High-dose Rhesus-Human Reassortant Rotavirus Vaccines—Report of the National Multicenter Trial Pediatrics. ,vol. 97, pp. 7- 13 ,(1996)
P. E. Kilgore, N. Luo, N. A. Cunliffe, J. S. Bresee, C. A. Hart, A. D. Steele, R. I. Glass, Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bulletin of The World Health Organization. ,vol. 76, pp. 525- 537 ,(1998)
Timo Vesikari, Aino Karvonen, Leena Puustinen, Shang-Qin Zeng, Evelyn Dora Szakal, Andrée Delem, Beatrice De Vos, Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants Pediatric Infectious Disease Journal. ,vol. 23, pp. 937- 943 ,(2004) , 10.1097/01.INF.0000141722.10130.50
G. Giammanco, V. De Grandi, L. Lupo, A. Mistretta, S. Pignato, D. Teuween, H. Bogaerts, F. E. Andre, Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine European Journal of Epidemiology. ,vol. 4, pp. 121- 123 ,(1988) , 10.1007/BF00152704
Sricharoen Migasena, Sriluck Simasathien, Rudiwilai Samakoses, Punnee Pitisuttitham, Preyapan Sangaroon, Gijsbert van Steenis, E. Coen Beuvery, Helen Bugg, Ruth Bishop, Bruce L. Davidson, Timo Vesikari, Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants Vaccine. ,vol. 13, pp. 168- 174 ,(1995) , 10.1016/0264-410X(95)93131-R
Patricia Matlai, Valerie Beral, Trends in congenital malformations of external genitalia. The Lancet. ,vol. 1, pp. 108- 108 ,(1985) , 10.1016/S0140-6736(85)91999-3
T Vesikari, A Karvonen, T Korhonen, M Espo, E Lebacq, J Forster, F Zepp, A Delem, B De Vos, Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. Vaccine. ,vol. 22, pp. 2836- 2842 ,(2004) , 10.1016/J.VACCINE.2004.01.044
S. Cadranel, S. Zeglache, T. Jonckheer, G. Zissis, F. E. Andre, H. Bogaerts, A. Delem, Factors affecting antibody response of newborns to repeated administrations of the rotavirus vaccine RIT 4237. Journal of Pediatric Gastroenterology and Nutrition. ,vol. 6, pp. 525- 528 ,(1987) , 10.1097/00005176-198707000-00005